Conrad Chan
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 20
- Monoclonal and Polyclonal Antibodies Research 9
- Medical Imaging Techniques and Applications 4
- Oncology 14
- HER2/EGFR in Cancer Research 11
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Raymond M. Reilly (30 shared papers)Zhongli Cai (14 shared papers)Katherine A. Vallis (2 shared papers)Deborah A. Scollard (7 shared papers)Jean‐Philippe Pignol (2 shared papers)Karen Lam (5 shared papers)Paul Chen (3 shared papers)Niladri Chattopadhyay (1 shared paper)
In The Last Decade
Conrad Chan
32 papers receiving 809 citations
Peers
Comparison fields: 5 of 82
- Radiology, Nuclear Medicine and Imaging 452
- Oncology 211
- Radiation 50
- Biomaterials 68
- Biophysics 29
Countries citing papers authored by Conrad Chan
This map shows the geographic impact of Conrad Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad Chan more than expected).
Fields of papers citing papers by Conrad Chan
This network shows the impact of papers produced by Conrad Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad Chan. The network helps show where Conrad Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Conrad Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 160 | |
| 2 | 2011 | 91 | |
| 3 | 2010 | 55 | |
| 4 | A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis. | 2005 | 45 |
| 5 | 2016 | 43 | |
| 6 | 2005 | 38 | |
| 7 | 2015 | 38 | |
| 8 | 2007 | 37 | |
| 9 | 2014 | 35 | |
| 10 | 2011 | 34 | |
| 11 | 2013 | 26 | |
| 12 | 2015 | 24 | |
| 13 | 2018 | 20 | |
| 14 | 2010 | 18 | |
| 15 | 2011 | 16 | |
| 16 | 2009 | 16 | |
| 17 | 2014 | 15 | |
| 18 | 2015 | 14 | |
| 19 | 2019 | 12 | |
| 20 | 2023 | 10 |
About Conrad Chan
Conrad Chan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Materials Chemistry, having authored 33 papers that have together received 819 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Medical Imaging Techniques and Applications (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Radiation Shielding Materials Analysis (2 papers), Advanced X-ray and CT Imaging (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (452 citations), Oncology (211 citations), Radiation (50 citations), Biomaterials (68 citations) and Biophysics (29 citations). Conrad Chan has collaborated with scholars based in Canada, Hong Kong and China. Frequent co-authors include Raymond M. Reilly, Zhongli Cai, Katherine A. Vallis, Deborah A. Scollard, Jean‐Philippe Pignol, Karen Lam, Paul Chen, Niladri Chattopadhyay, Judy Wang and Mark N. Levine. Their work appears in journals such as Nuclear Medicine and Biology, Molecular Pharmaceutics, EJNMMI Radiopharmacy and Chemistry, Journal of Nuclear Medicine and Applied Radiation and Isotopes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.